Boralex Inc.
BRLXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.56 | 0.05 | -7.31 | -2.47 |
| FCF Yield | -7.45% | 6.35% | 6.44% | 4.67% |
| EV / EBITDA | 12.91 | 11.09 | 16.75 | 15.44 |
| Quality | ||||
| ROIC | 2.17% | 2.74% | 0.81% | 1.92% |
| Gross Margin | 100.00% | 62.82% | 69.14% | 77.86% |
| Cash Conversion Ratio | 2.91 | 4.31 | 64.13 | 13.27 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.67% | 13.94% | 9.72% | 6.38% |
| Free Cash Flow Growth | -209.72% | -16.60% | 56.02% | -19.42% |
| Safety | ||||
| Net Debt / EBITDA | 6.95 | 5.32 | 7.48 | 7.82 |
| Interest Coverage | 1.85 | 1.70 | 0.96 | 1.33 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 19.85 | 0.00 |
| Cash Conversion Cycle | 112.97 | 47.79 | 39.92 | -29.18 |